Noradrenaline (Norepinephrine) 1:1000, Concentrate for Solution for Infusion
*Company:
Pfizer Healthcare IrelandStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 14 February 2023
File name
DEC202126552_Reg SPC gxNO 3_2 1mg_ml IE Clean.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 31 October 2022
File name
Reg PIL gxNO 6_2 1mg ml IE Clean.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 20 April 2021
File name
DEC202126552_Reg SPC gxNO 3_2 1mg_ml IE Clean.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 20 April 2021
File name
DEC202126552_Reg PIL gxNO 5_1 1mg_ml IE Clean.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 03 August 2018
File name
CLEAN Reg PIL gxNO 2_0 1mg_ml IE.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 03 August 2018
File name
clean Reg SPC gxNO 2_0 1mg_ml IE.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
|
For SPC changes: sections 7, 8 & 10 (MAH change, License number change and |
Updated on 22 May 2018
File name
Clean_Reg_SPC_gxNI_1_0_1mg_ml_IE.docx
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
|
Please update medicines.ie |
Changes were:
The addition of stress cardiomyopathy to section 4.8, Undesirable Effects
|
And, a change to the revision date in section 10 |
Updated on 25 January 2018
File name
PIL_17286_775.pdf
Reasons for updating
- New PIL for new product
Updated on 11 September 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)